Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01523/full |
| _version_ | 1828529593581043712 |
|---|---|
| author | Hao Chen Hao Chen Wei Chong Qian Wu Yueliang Yao Min Mao Xin Wang |
| author_facet | Hao Chen Hao Chen Wei Chong Qian Wu Yueliang Yao Min Mao Xin Wang |
| author_sort | Hao Chen |
| collection | DOAJ |
| first_indexed | 2024-12-11T22:10:09Z |
| format | Article |
| id | doaj.art-81e2207ddb1d4ff6897a2d5f2604a700 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-12-11T22:10:09Z |
| publishDate | 2019-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-81e2207ddb1d4ff6897a2d5f2604a7002022-12-22T00:48:48ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-07-011010.3389/fimmu.2019.01523479028Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point BlockadesHao Chen0Hao Chen1Wei Chong2Qian Wu3Yueliang Yao4Min Mao5Xin Wang6Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, ChinaKey Laboratory of Cancer Prevention and Therapy of Tianjin, Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaKey Laboratory of Cancer Prevention and Therapy, Department of Breast Cancer Pathology and Research Laboratory, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, ChinaDepartment of Respiratory Medicine, Central Hospital of Zibo, Zibo, ChinaInstitute of Pathology and Southwest Cancer Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, ChinaKey Laboratory of Tumor Immunopathology, Ministry of Education of China, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, ChinaDepartment of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, Chinahttps://www.frontiersin.org/article/10.3389/fimmu.2019.01523/fullLRP1BmelanomaNSCLCtumor mutation burdenimmunotherapymutation signatures |
| spellingShingle | Hao Chen Hao Chen Wei Chong Qian Wu Yueliang Yao Min Mao Xin Wang Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades Frontiers in Immunology LRP1B melanoma NSCLC tumor mutation burden immunotherapy mutation signatures |
| title | Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades |
| title_full | Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades |
| title_fullStr | Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades |
| title_full_unstemmed | Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades |
| title_short | Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades |
| title_sort | corrigendum association of lrp1b mutation with tumor mutation burden and outcomes in melanoma and non small cell lung cancer patients treated with immune check point blockades |
| topic | LRP1B melanoma NSCLC tumor mutation burden immunotherapy mutation signatures |
| url | https://www.frontiersin.org/article/10.3389/fimmu.2019.01523/full |
| work_keys_str_mv | AT haochen corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT haochen corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT weichong corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT qianwu corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT yueliangyao corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT minmao corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades AT xinwang corrigendumassociationoflrp1bmutationwithtumormutationburdenandoutcomesinmelanomaandnonsmallcelllungcancerpatientstreatedwithimmunecheckpointblockades |